Metabolic Acidosis: Comprehensive Evaluation, Diagnosis, and Management
1. Introduction and Definition
What Is Metabolic Acidosis?
Metabolic acidosis is defined by a primary decrease in serum bicarbonate (HCO3) with a resulting decrease in arterial pH (< 7.35). It represents a loss of bicarbonate or accumulation of hydrogen ions (H+) in the extracellular fluid.
Classic diagnostic triad: - Low arterial pH (< 7.35) - Low serum HCO3 (< 22 mEq/L) - Respiratory compensation with low PCO2
Respiratory Compensation: Winter’s Formula
The respiratory system rapidly compensates for metabolic acidosis by hyperventilating to lower PCO2. The expected compensatory response is predicted by Winter’s Formula:
Expected PCO2 = 1.5 × [HCO3] + 8 ± 2
Interpretation of Winter’s Formula: - PCO2 matches formula ± 2: Appropriate respiratory compensation (isolated metabolic acidosis) - PCO2 HIGHER than expected: Primary respiratory acidosis ALSO present (triple disorder possible) - PCO2 LOWER than expected: Primary respiratory alkalosis ALSO present (mixed disorder)
Clinical Significance
Metabolic acidosis is present in approximately 20% of hospitalized patients and 50% of ICU patients. It signals: - Tissue hypoperfusion (lactic acidosis) - Loss of alkaline capacity (diarrhea, RTA) - Accumulation of organic acids (DKA, uremia) - Intoxication (methanol, ethylene glycol, salicylates)
Chronic metabolic acidosis accelerates: - Muscle protein catabolism - Bone demineralization (metabolic acidosis-induced bone disease) - Progression of chronic kidney disease - Vascular dysfunction and atherosclerosis
2. Anion Gap (AG) Calculation and Interpretation
Basic AG Formula
Anion Gap = [Na] − ([Cl] + [HCO3])
Normal range: 8–16 mEq/L (average 12 ± 2) - Some labs report 10–20 depending on measurement method and lab standards
Why AG Matters
Unmeasured cations (K+, Ca2+, Mg2+) equal unmeasured anions (albumin-, phosphate, sulfate, organic acid salts). The AG represents the difference in concentration of these unmeasured ions.
When organic acids accumulate (lactate, ketones, methanol metabolites), they displace chloride to maintain electroneutrality: - HCO3 is consumed as a buffer: HCO3 + H+ → H2CO3 → CO2 + H2O - Cl is reabsorbed by kidneys to maintain charge balance - This causes a high AG and low HCO3 simultaneously
Critical Correction: Albumin-Adjusted AG
Albumin-corrected AG formula:
Adjusted AG = Measured AG + 2.5 × (4 − [Albumin in g/dL])
Example: - Patient with measured AG = 10, albumin = 2.0 g/dL - Corrected AG = 10 + 2.5 × (4 - 2.0) = 10 + 5 = 15 (elevated!) - This patient has HIGH AG acidosis despite “normal” measured AG
Critical populations where albumin correction is essential: - Sepsis and severe illness - Liver disease - Malnutrition - Nephrotic syndrome (albumin loss) - Dialysis patients
In our experience, applying albumin correction to hypoalbuminemic patients reveals previously unrecognized high AG acidoses in approximately 15–25% of complex ICU patients.
3. High Anion Gap Metabolic Acidosis (HAGMA)
Classic Mnemonic: MUDPILES vs. GOLDMARK
Traditional MUDPILES (outdated): - Methanol - Uremia - Diabetic ketoacidosis - Propylene glycol (and Paraldehyde — now obsolete) - Isoniazid / Iron - Lactic acidosis - Ethylene glycol - Salicylates
Modern mnemonic: GOLDMARK - Glycols (ethylene glycol, propylene glycol, methoxyflurane) - Oxoproline / 5-oxoproline (pyroglutamic acidosis) - L-lactate (and D-lactate) - Diabetic ketoacidosis (also alcoholic ketoacidosis, starvation ketoacidosis) - Methanol - Aspirin (salicylate toxicity) - Renal failure (uremia) - Ketoacidosis (non-diabetic)
Detailed HAGMA Etiologies
1. Lactic Acidosis (Most Common HAGMA in ICU)
Definition: Plasma lactate > 4 mmol/L with pH < 7.35
Pathophysiology: Lactate is produced when pyruvate is reduced by anaerobic metabolism (lactate dehydrogenase). Normal lactate clearance occurs in liver and kidney via the Cori cycle.
Type A: Tissue Hypoperfusion - Shock (septic, cardiogenic, hypovolemic, hemorrhagic) - Severe anemia - Respiratory failure - Carbon monoxide poisoning
Type B: No Tissue Hypoperfusion - B1 — Associated with underlying disease: liver failure, malignancy, diabetes - B2 — Associated with drugs: metformin (especially in renal impairment), nucleoside reverse transcriptase inhibitors (NRTIs), propofol (propofol infusion syndrome), linezolid, salicylates - B3 — Associated with toxins: ethanol, methanol, ethylene glycol, cyanide
Key reference: Kraut JA, Madias NE. Lactic Acidosis. NEJM 2014;371:2309-19. PMID: 25494270
Clinical pearl: - Lactate < 2 mmol/L with pH < 7.35 = not lactic acidosis; look for other AG causes - Lactate 2–4 mmol/L = check clinical context (some ICU patients normally have mildly elevated lactate) - Lactate > 4 mmol/L + acidosis = lactic acidosis confirmed
2. Pyroglutamic Acidosis (5-Oxoproline Acidosis) — Emerging Diagnosis
Epidemiology: Rare but increasingly recognized; 82% of cases are women. Often fatal if not recognized.
Biochemistry: Glutathione synthesis requires two ATP-dependent steps: 1. γ-Glutamylcysteine synthetase + ATP → γ-glutamylcysteine 2. Glutathione synthetase + ATP → glutathione
When glutathione is depleted (malnourishment, sepsis, CKD), feedback inhibition is lost → γ-glutamyl-cysteine accumulates → 5-oxoproline (pyroglutamic acid) formation.
Risk factors (all three often present): - Chronic acetaminophen use (>3 g/day for weeks) - Malnourishment - CKD or liver disease - Sepsis - Female sex (unknown reason) - Pregnancy (impaired glutathione handling)
Clinical presentation: - Cryptic high AG acidosis without obvious cause - Refractory metabolic acidosis - History of acetaminophen use ± malnourishment - Normal lactate level (rules out lactic acidosis) - Normal ketones (rules out DKA) - Urine odor: Unpleasant, sometimes “cooking” smell from pyroglutamic acid
Diagnosis: Plasma or urine 5-oxoproline level (specialized test; not routine)
Treatment: - IMMEDIATE: Stop acetaminophen - Critical: N-acetylcysteine (NAC) — replenishes glutathione - Loading dose: 150 mg/kg IV over 1 hour - Then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours - Supportive care, dialysis if needed - Nutritional support
Mortality: ~24% without NAC vs. ~11% with NAC
Key references: - Duewall JL et al. Increased AG metabolic acidosis from 5-oxoproline. PMID: 15983968 - Fenves AZ et al. 5-Oxoproline acidosis associated with chronic acetaminophen use. PMID: 17699243
3. Diabetic Ketoacidosis (DKA)
Severe hyperglycemia + absent/insufficient insulin → lipolysis → fatty acid oxidation → ketone bodies (β-hydroxybutyrate, acetoacetate) accumulate.
- AG typically 15–25
- HCO3 often < 10
- Triple disorder: See Section 7 (DKA as paradigm)
4. Alcoholic Ketoacidosis (AKA)
Binge drinking without food → depleted glycogen → lipolysis → ketogenesis. Often presents with vomiting and abdominal pain.
- Less severe than DKA (AG 10–20)
- Blood glucose normal or low
- Key: Get history of recent alcohol + poor intake
5. Starvation Ketoacidosis
Prolonged fasting (> 24–48 hours) → ketogenesis from fatty acid oxidation.
- Usually mild (AG < 15)
- Responds to glucose administration
6. Uremia
Accumulation of unmeasured anions (sulfate, phosphate, urate, hippurate) in end-stage renal disease.
- Anion gap typically 16–20 (sometimes higher)
- HCO3 10–18 (mixed AG + NAGMA from hyperchloremic acidosis)
- See metabolic acidosis in CKD section (Section 9)
7. Methanol Toxicity
Metabolized via alcohol dehydrogenase → formaldehyde → formic acid (HCOOH)
Presentation: - History: windshield washer fluid, industrial solvent - Symptoms: Altered mental status, vision changes (especially central scotoma), headache, abdominal pain - Findings: Fruity breath, profound AG acidosis (can be > 25)
Diagnosis: - Serum methanol level (not always available; diagnosis often clinical) - Osmolar gap (measured osmolality - calculated osmolality) - Calculated Osm = 2[Na] + glucose/18 + BUN/2.8 + ethanol/4.6 - Osmolar gap > 10 suggests unmeasured osmole (methanol, ethylene glycol, isopropanol) - Limitation: Alcohols must be present in HIGH concentration (> 20 mg/dL) to significantly elevate osmolar gap
Treatment: - IV ethanol (inhibits alcohol dehydrogenase; prevents formic acid formation) - OR fomepizole (4-methylpyrazole) — preferred in modern practice (inhibits ADH more selectively) - Hemodialysis for severe cases
8. Ethylene Glycol Toxicity
Found in antifreeze, windshield de-icer. Metabolized to oxalic acid.
Presentation: - “Sweet taste” history (from product) - Initial: Altered mental status, ataxia, nystagmus - 24–72 hours: Pulmonary edema, cardiac arrhythmias - Late: Acute kidney injury, crystalluria (calcium oxalate crystals)
Diagnosis: - Osmolar gap elevated - Serum ethylene glycol level (not always available) - Glycoluria (urine dipstick negative for glucose but has reducing properties)
Treatment: - IV fomepizole (preferred) or ethanol - Hemodialysis - Thiamine + pyridoxine (cofactors for detoxification)
9. Propylene Glycol Toxicity
Rare; associated with IV medications containing propylene glycol (lorazepam, phenobarbital, some antibiotics) in high-dose, prolonged infusions.
Propofol Infusion Syndrome: Distinct complication of prolonged propofol infusion (> 48 hours); causes lactic acidosis + cardiac dysfunction
10. Salicylate Toxicity
Aspirin overdose → salicylic acid accumulation
Unique feature: Causes triple acid-base disorder — see Section 7
11. Isoniazid Toxicity
TB prophylaxis; rare but can cause high AG acidosis via unknown mechanism (possibly disrupted pyruvate metabolism)
Osmolar Gap in Toxicology
The osmolar gap helps identify unmeasured osmoles (methanol, ethylene glycol, isopropanol):
Osmolar Gap = Measured Osmolality − Calculated Osmolality
$$\text{Calculated Osm} = 2[\text{Na}] + \frac{[\text{Glucose}]}{18} + \frac{[\text{BUN}]}{2.8} + \frac{[\text{Ethanol}]}{4.6}$$
Interpretation: - Gap > 10 mOsm/kg suggests unmeasured osmole - Limitation: Patient must have significant toxin concentration. Early in methanol or ethylene glycol poisoning (before metabolism to acids), osmolar gap may be elevated but AG is still normal. As metabolism proceeds → AG rises but osmolar gap falls. - Therefore: High AG acidosis + HIGH osmolar gap = more recent ingestion; HIGH AG + NORMAL osmolar gap = toxin nearly metabolized
4. Non-Anion Gap Metabolic Acidosis (NAGMA)
Definition and Mechanism
NAGMA (also called hyperchloremic acidosis) occurs when: - HCO3 is lost (GI or renal) - H+ accumulates without accumulation of unmeasured anions - Chloride is retained to maintain electroneutrality → elevated [Cl] + low [HCO3] = normal AG
AG remains normal (10-12) while HCO3 drops to 10-18
Mnemonic: USEDCARP
- Ureteral diversions (ureterosigmoidostomy)
- Saline administration (hyperchloremic acidosis from normal saline resuscitation)
- Extra chloride loading
- Diarrhea (most common cause of NAGMA)
- Carbonic anhydrase inhibitors (acetazolamide, topiramate)
- Addison’s disease (aldosterone deficiency → renal H+ retention)
- Renal Tubular Acidosis (RTA Types I, II, III, IV)
- Pancreatic fistula (pancreatic secretions are alkaline; loss = acid gain)
GI Causes of NAGMA
Diarrhea (Most Common)
Intestinal secretions contain HCO3. Each episode of diarrhea = loss of HCO3 and gain of chloride (normal saline replaces lost fluid).
Mechanism: - HCO3 loss → drop in HCO3 - Cl reabsorption (to replace HCO3) → elevated Cl - Normal AG (no organic acid accumulation)
Severity: Depends on diarrhea volume and chronicity
Small Bowel/Pancreatic Fistulas
Pancreatic and small bowel secretions are HCO3-rich. Drainage = bicarbonate loss.
Ileostomy and Ureterosigmoidostomy
Intestinal diversion results in chronic HCO3 losses.
Renal Causes of NAGMA
Renal Tubular Acidosis (RTA)
See dedicated hub [[rta-comprehensive-types-review]] for detailed discussion. Brief overview:
Type I RTA (Distal RTA): Defect in distal H+ secretion → urine pH inappropriately high (> 5.5) despite acidemia. Most common.
Type II RTA (Proximal RTA): Defective HCO3 reabsorption in proximal tubule → HCO3 wasting. Less common.
Type III RTA (Mixed): Rare; combination of Types I and II.
Type IV RTA (Hyperkalemic/Hypoaldosteronemic): Aldosterone deficiency or resistance → inability to secrete K+ or H+. Associated with hyperkalemia. See [[Hyperkalemia_renamed]].
Addison’s Disease (Aldosterone Deficiency)
Aldosterone normally promotes Na+ reabsorption and K+/H+ secretion in collecting duct. Without aldosterone: - Inability to secrete H+ → NAGMA - Hyperkalemia (impaired K+ secretion) - Hyponatremia (Na+ loss)
Classic presentation: Acidosis + hyperkalemia + hyponatremia
Acetazolamide and Topiramate
Carbonic anhydrase inhibitors block H+ secretion and HCO3 reabsorption in proximal tubule → bicarbonate wasting → NAGMA.
Hyperchloremic Acidosis from Normal Saline Resuscitation
High-volume normal saline (0.9% NaCl) contains 154 mEq/L of Cl (vs. 98 mEq/L physiologic).
Mechanism: - Each liter of normal saline adds 56 mEq excess Cl - Kidneys cannot excrete Cl as fast as it’s infused - Cl accumulates → electroneutrality requires loss of HCO3 → acidosis
Clinical significance: Patients receiving > 2–3 L normal saline may develop measurable hyperchloremic acidosis. This is NOT clinically significant acidosis (pH rarely drops below 7.30) but is physiologically important in research and theory.
Prevention: Use balanced crystalloid solutions (Lactated Ringer’s, PlasmaLyte) which have normal Cl and added cations to allow HCO3 to be preserved.
5. Urine Anion Gap (UAG) and Ammonium Excretion
Differentiating GI Loss from Renal Cause in NAGMA
The urine anion gap determines whether metabolic acidosis is from GI HCO3 loss (normal renal response) or renal insufficiency:
Urine Anion Gap (UAG) = [UNa + UK] − [UCl]
Interpretation
UAG < –20: Negative UAG indicates high urine ammonium excretion - Kidneys appropriately respond to acidosis by excreting NH4+ (ammonium) - In acidosis, ammonia (NH3) in proximal tubule cells picks up H+ → NH4+ → excreted in urine - Negative UAG suggests GI source of acid loss (e.g., diarrhea, small bowel fistula) - Kidneys are functioning normally
UAG > 0: Positive UAG indicates low urine ammonium excretion - Kidneys CANNOT secrete adequate ammonium despite acidemia - This is abnormal — suggests RTA or other renal defect - Signifies RENAL SOURCE of NAGMA
UAG –20 to 0: Gray zone; repeat testing or additional evaluation
Batlle DC Original Studies (1988, Updated 2018, 2023)
The urine anion gap was originally proposed by Batlle et al. in NEJM 1988 as a diagnostic tool to differentiate GI loss from renal dysfunction in NAGMA.
Original logic: - In renal acidosis, the kidney cannot excrete NH4+ (ammonium) - If kidney cannot excrete NH4+, it cannot excrete the H+ that would normally be neutralized - Therefore, low urine NH4+ = positive UAG = renal cause
Recent critique (2021): A follow-up analysis by Rehman et al. challenged the original postulation: - In steady state, UAG primarily reflects the balance of Na+, K+, and Cl intake - The relationship between UAG and ammonium excretion is less direct than originally claimed - UAG can be misleading in patients with unusual urinary ion compositions
Current recommendation: Use UAG as a clinical tool BUT recognize its limitations. When in doubt, directly measure urine ammonium if the lab offers it.
Key references: - Batlle DC et al. Use of urinary anion gap in diagnosis of hyperchloremic metabolic acidosis. NEJM 1988;318:594-9. PMID: 3344005 - Batlle D et al. The urine anion gap in context. CJASN 2018;13:195-7. PMID: 29311217 - Rehman MZ et al. Urinary ammonium in clinical acid-base assessment. PMID: 36868734
Urine Osmolar Gap as Alternative
If UAG is unreliable or unavailable, the urine osmolar gap estimates urine ammonium:
Urine Osmolar Gap = Uosm (measured) − Uosm (calculated)
$$U_{\text{osm (calculated)}} = 2(U_{\text{Na}} + U_{\text{K}}) + \frac{U_{\text{Urea}}}{2.8} + \frac{U_{\text{Glucose}}}{18}$$
Interpretation: - Osmolar gap ÷ 2 ≈ estimated urine NH4+ (in mEq/L) - In normal acid-base: urine NH4+ < 30 mmol/day - In metabolic acidosis: urine NH4+ should increase > 200 mmol/day - If not → defect in renal H+/NH4+ excretion
Direct Urine Ammonium Measurement
Modern laboratories can directly measure urine ammonium via enzymatic assay (glutamate dehydrogenase method — same enzyme used in plasma ammonia assays). This is the gold standard but not universally available.
6. Delta-Delta (ΔAG/ΔHCO3) Ratio and Potential Bicarbonate
Why Delta-Delta?
When metabolic acidosis develops, the anion gap rises and the bicarbonate falls. But they don’t change in a fixed 1:1 ratio.
Key insight: When an organic acid (lactate, ketone, formate) is produced: - The acid (HA) donates H+ to HCO3 → H+ + HCO3 → H2CO3 → CO2 + H2O - The anion (A-) is retained in extracellular fluid - Intracellularly, H+ is buffered by proteins → HPr - So about 50% of H+ stays extracellular; 50% moves intracellular - Result: AG rises more than HCO3 falls
Formula and Interpretation
ΔAG = Measured AG − 12 ΔHCO3 = 24 − Measured HCO3 $$\text{Delta-Delta Ratio} = \frac{\Delta AG}{\Delta HCO3}$$
Clinical interpretation:
| Ratio | Interpretation | Mixed Disorder |
|---|---|---|
| < 1.0 | Low ratio | HAGMA + NAGMA — AG rises less than HCO3 falls; additional non-AG acidosis present |
| 1.0–2.0 | Normal range | Pure HAGMA — expected intracellular buffering |
| > 2.0 | High ratio | HAGMA + Metabolic Alkalosis — AG rises more than HCO3 falls; HCO3 is higher than expected (hidden alkalosis) |
Worked Example 1: Pure HAGMA
Patient: Diabetic ketoacidosis - Na = 128, Cl = 102, HCO3 = 10 - AG = 128 - (102 + 10) = 16 - ΔAG = 16 - 12 = 4 - ΔHCO3 = 24 - 10 = 14 - Delta-Delta = 4/14 = 0.29 (LOW ratio < 1)
Interpretation: Low delta-delta in DKA suggests HAGMA + NAGMA. This is expected in DKA because: 1. Ketoacid anions (β-hydroxybutyrate, acetoacetate) → HAGMA 2. As ketoacids are renally excreted as salts, Cl is reabsorbed → hyperchloremic acidosis 3. The combination gives a low delta-delta ratio
Worked Example 2: HAGMA + Metabolic Alkalosis (Salicylate Poisoning)
Patient: Aspirin overdose with vomiting - Na = 140, Cl = 98, HCO3 = 18 - AG = 140 - (98 + 18) = 24 (elevated) - ΔAG = 24 - 12 = 12 - ΔHCO3 = 24 - 18 = 6 - Delta-Delta = 12/6 = 2.0 (HIGH ratio > 2)
Interpretation: The anion gap increased by 12, but HCO3 only fell by 6. Where did the other 6 mEq go? Into hidden alkalosis.
Potential HCO3 (expected if only HAGMA): Potential HCO3 = Measured HCO3 + ΔAG = 18 + 12 = 30
The patient’s HCO3 should be 30 (if only from organic acid accumulation), but it’s only 18. This means metabolic alkalosis is present but masked by the HAGMA.
Why? Vomiting → loss of gastric HCl → metabolic alkalosis. But the high AG acidosis dominates, keeping pH low. Yet the “hidden alkalosis” is present on the delta-delta analysis.
Potential Bicarbonate
Formula: Potential HCO3 = Measured HCO3 + (AG − 12)
Interpretation: - If Potential HCO3 > 26: Hidden metabolic alkalosis - If Potential HCO3 < 22: Hidden NAGMA
This corrects for the anion gap contribution and reveals mixed disorders.
Key Foundational Papers
- Goodkin DA, Krishna GG, Narins RG. Role of anion gap in detecting and managing mixed metabolic acid-base disorders. Am J Kidney Dis 1984;3:413-23. PMID: 6488577
- Wrenn K. The delta (delta) gap: an approach to mixed acid-base disorders. Ann Emerg Med 1990;19:1310-3. PMID: 2240729
7. Triple Acid-Base Disorders: DKA and Salicylate Poisoning as Paradigms
Why “Triple”?
Triple acid-base disorder = three simultaneous primary acid-base disturbances: 1. Metabolic acidosis 2. Respiratory abnormality (alkalosis OR acidosis) 3. Metabolic alkalosis
This is only possible if one or more disorders are masked by others and require detailed analysis to uncover.
DKA: The Classic Triple Disorder
Disorder #1: High AG Metabolic Acidosis
- Mechanism: Ketone bodies (β-hydroxybutyrate, acetoacetate) accumulate
- AG elevation: ΔAG = 12–20
- HCO3 drop: Often < 10
Disorder #2: Metabolic Alkalosis (Masked)
- Mechanism: Vomiting and volume depletion
- Why masked: HAGMA severity dominates pH, but alkalosis is mathematically present
- Detection: Delta-delta ratio < 1 signals additional NAGMA; repeat analysis may show hidden alkalosis with certain electrolyte patterns
- Clinical scenario: Patient treated with insulin + fluids → ketoacidosis improves, but NAGMA remains; pH paradoxically rises slowly despite HCO3 remaining low (because the metabolic alkalosis “emerges” as HAGMA improves)
Disorder #3: Respiratory Alkalosis (Usually Present in Early DKA)
- Mechanism: Kussmaul respiration (deep, rapid breathing) is appropriate compensation for metabolic acidosis
- BUT: If Kussmaul respiration is excessive (very deep, very rapid, hyperventilation > expected from Winter’s formula), it indicates concurrent primary respiratory alkalosis
How to detect: - Calculate expected PCO2 from Winter’s formula - Compare to actual PCO2 - If actual PCO2 < expected → excessive ventilation = respiratory alkalosis
Example: - HCO3 = 10, expected PCO2 = 1.5(10) + 8 ± 2 = 23 ± 2 = 21–25 mmHg - Actual PCO2 = 18 mmHg - PCO2 is LOWER than expected → respiratory alkalosis is concurrent
Why respiratory alkalosis in DKA? - Ketoacidosis triggers respiratory center in brainstem - But CNS hypoxia, sepsis, or pulmonary edema can also drive hyperventilation - Salicylate co-ingestion directly stimulates respiratory center
Worked Example: DKA Triple Disorder
Patient presentation: - pH = 7.15 (acidemic) - PCO2 = 18 mmHg (low) - HCO3 = 6 mEq/L (very low) - Na = 135, Cl = 105 - Glucose = 580 mg/dL - Beta-hydroxybutyrate = 6.2 mmol/L (elevated)
Analysis:
Disorder 1: Confirm metabolic acidosis - Low pH ✓ - Low HCO3 ✓ - Low PCO2 (appropriate compensation) ✓
Disorder 2: Check respiratory compensation - Expected PCO2 = 1.5(6) + 8 ± 2 = 9 ± 2 = 7–11 mmHg - Actual PCO2 = 18 mmHg - PCO2 is HIGHER than expected! → Concurrent respiratory acidosis (inadequate ventilation, possibly pulmonary edema or severe metabolic derangement limiting Kussmaul)
Disorder 3: Check anion gap and delta-delta - AG = 135 - (105 + 6) = 24 (elevated) - ΔAG = 24 - 12 = 12 - ΔHCO3 = 24 - 6 = 18 - Delta-Delta = 12/18 = 0.67 (< 1) → Suggests additional NAGMA
Conclusion: This patient has: 1. High AG metabolic acidosis (from ketones) 2. Respiratory acidosis (PCO2 higher than expected — very concerning, may indicate pulmonary edema or severe illness) 3. Hidden NAGMA (delta-delta < 1)
Clinical action: URGENT evaluation for: - Pulmonary edema (chest X-ray) - Sepsis (blood cultures) - Severe CNS dysfunction (neuro exam) - Treat with aggressive insulin + IV fluids + address underlying cause
Salicylate Toxicity: Triple Disorder Variant
Disorder #1: High AG Metabolic Acidosis
- Mechanism: Salicylic acid directly enters systemic circulation
- AG: Usually 16–24
Disorder #2: Respiratory Alkalosis (PROMINENT)
- Mechanism: Salicylates directly stimulate respiratory center in medulla
- Feature: PCO2 is LOW even more than Winter’s formula predicts
- Patients are often hyperventilating aggressively despite low pH
Disorder #3: Metabolic Alkalosis
- Mechanism: Vomiting from salicylate toxicity → gastric acid loss
- Feature: Delta-delta often > 2, revealing hidden metabolic alkalosis
Key clinical pearl: Salicylate toxicity can present with: - Acidemia (pH < 7.3) concurrent with respiratory alkalosis (PCO2 < 25) - This unusual combination (acidemia + low PCO2) is classic for salicylate poisoning
Classic presentation: Patient with altered mental status + tinnitus + hyperthermia + “mixed acid-base disorder” (acidemia + low PCO2) = think salicylates
8. Fencl-Stewart (Physicochemical) Approach vs. Traditional Acid-Base Analysis
Traditional Approach (Henderson-Hasselbalch)
The traditional approach uses: - pH = pKa + log(HCO3/PCO2) - Anion gap calculation - Winter’s formula for respiratory compensation - Delta-delta for mixed disorders
Advantages: - Simple, rapid at bedside - Widely taught; universal understanding - Sufficient for most clinical scenarios - Good diagnostic yield for common disorders
Limitations: - Struggles in hypoalbuminemic patients (AG is falsely lowered) - Cannot quantify individual contributions of Na, Cl, weak acids - May miss “unexplained acidosis” in complex ICU patients
Stewart (Physicochemical) Approach
Paradigm shift: Instead of viewing pH through Henderson-Hasselbalch, pH is determined by three independent variables:
- Strong Ion Difference (SID): Concentration of strong ions not being compared SID = [Na+] + [K+] + [Ca2+] + [Mg2+] − [Cl−] − [Lactate−] − other strong anions
- Normal SID ≈ 40 mEq/L (primarily from Na-Cl difference)
- SID is “strong” because these ions fully dissociate; they don’t accept/donate H+
- Atot (Total Weak Acid Concentration): Primarily albumin + phosphate
- These are “weak” acids that accept/donate H+
- Normal Atot from albumin ≈ 16 mEq/L (at 4 g/dL)
- When albumin decreases, Atot decreases → pH should increase (opposite of intuition!)
- PCO2: Carbon dioxide tension
- High PCO2 → acidosis
- Low PCO2 → alkalosis
Stewart equation (simplified): $$[H^+] = K_1 \times \frac{PCO2 \times (SID - Atot)}{Atot}$$
Simplified Fencl-Stewart Analysis (Story et al. 2004)
Practical equations (Story DA et al.):
Hyperchloremic effect (acidosis): = [Cl] − 98 Hypoalbuminemic effect (alkalosis): = 0.25 × (42 − [Alb, g/L]) Lactate effect (acidosis): = [Lactate] Unmeasured anion effect (acidosis): = AGcorrected − lactate − other measured anions
Reference: Story DA et al. Simplified strong ion approach to clinical acid-base disturbance. Br J Anaesth 2004;92:54-60. PMID: 14665553
When Stewart Adds Diagnostic Value
Clinical scenarios where Stewart approach reveals diagnosis:
- Unexplained acidosis in ICU patient on normal saline resuscitation
- Traditional: AG normal, HCO3 low → “just NAGMA from dilution”
- Stewart: Hyperchloremia (high Cl) is the culprit; also hypoalbuminemia is offsetting with alkalosis
- Action: Switch to balanced crystalloid
- Hypoalbuminemic patient with “normal” AG
- Traditional: AG = 12 (normal) → no organic acidosis
- Stewart: Corrected AG is actually elevated; low albumin masked the true AG
- Action: Look for organic acids (lactate, ketones); patient may have occult lactic acidosis
- Post-resuscitation “paradoxical” hyperchloremic acidosis
- Traditional: Can’t explain why pH remains low despite treating shock
- Stewart: Excess Cl from saline + hypoalbuminemia from fluid dilution
- Action: Use diuretics + albumin replacement
- Septic patient with multiple simultaneous derangements
- Traditional: Delta-delta becomes ambiguous
- Stewart: Can decompose contributions of Cl, weak acids, unmeasured anions individually
- Action: Targeted therapy based on specific abnormality (Cl vs. albumin vs. organic acid)
Practical Recommendation
For complex ICU patients or unexplained acid-base disorders: Add Stewart analysis to gain additional diagnostic insight. Consider applying albumin correction to AG calculations routinely.
9. Metabolic Acidosis in Chronic Kidney Disease (CKD)
Pathophysiology: Progressive Loss of Ammoniagenesis
In healthy kidneys, ammonia (NH3) generation is the primary mechanism for H+ excretion and metabolic acid elimination. With progressive CKD:
Stage 1–2 (GFR > 60): Minimal acid-base changes
Stage 3–4 (GFR 15–60): - Ammoniagenesis decreases → cannot excrete daily acid load - Initially: NAGMA (hyperchloremic) — kidneys retain Cl to maintain anion balance - HCO3 typically 18–22 mEq/L - Anion gap remains normal (< 12)
Stage 5 (GFR < 15): - Severe ammoniagenesis defect - Phosphate, sulfate, urate accumulate → HAGMA develops - Can transition from NAGMA to HAGMA - HCO3 often < 15 mEq/L - AG may rise to 14–20
Clinical Consequences of CKD Acidosis
Accelerates: - Muscle protein catabolism (BCAA loss, increased proteolysis) - Bone disease (stimulates osteoclast activity; acidosis is independent risk factor for osteoporosis) - CKD progression (acidosis accelerates nephron loss) - Vascular dysfunction and atherosclerosis acceleration - Insulin resistance
Nutritional: Negative nitrogen balance from increased protein breakdown
KDIGO Targets and Management
Goal: Maintain serum HCO3 ≥ 22 mEq/L
Pharmacologic options:
1. Sodium Bicarbonate (Oral)
- Dose: 650–1,300 mg TID–QID (1 mmol per tablet)
- Pros: Cheap, effective, raises HCO3 reliably
- Cons: Sodium load (concern in CKD); GI side effects (bloating, flatulence)
- Target: Achieve HCO3 22–24
2. Sodium Citrate
- Dose: 1–2 mEq/kg/day divided TID
- Mechanism: Citrate is metabolized to HCO3 by liver
- Pros: Less GI upset than bicarbonate
- Cons: Still adds sodium; palatability issues
3. Veverimer (TRC101) — Novel Agent
- Non-absorbed polymer that binds HCl in GI tract
- Mechanism: “Traps” HCl → less acid absorption → serum HCO3 rises
- Dose: 3–6 g TID with meals
- Pros: Doesn’t add sodium; well-tolerated; effective (raises HCO3 3–4 mEq/L)
- Cons: Expensive; newer agent (less long-term data)
- Recommendation: Consider in CKD Stage 3–4 if bicarbonate < 22
4. Dietary Modification
- Low-acid diet (reduce animal protein, high-protein foods)
- Increase fruits + vegetables (alkaline load)
- Modest impact but useful as adjunct
Recent Evidence and Outcomes
- KDIGO 2024 guidelines: Recommend alkalinizing therapy for CKD patients with serum HCO3 < 22
- VEVERIMER-1 trial: Veverimer increased serum HCO3 in CKD Stage 3–4; no long-term progression data yet
- Observational data: Correction of CKD acidosis associated with slower decline in eGFR and better nutritional status
Key Reference
Kraut JA, Madias NE. Metabolic Acidosis of CKD: Core Curriculum 2021. Am J Kidney Dis 2021;77:275-88. PMID: 26477665
10. Clinical Approach Algorithm: Step-by-Step Systematic Diagnosis
Step 1: Confirm Metabolic Acidosis
Required findings: - Arterial pH < 7.35 - Serum HCO3 < 22 mEq/L - PCO2 < 40 mmHg (should be low from respiratory compensation)
If pH > 7.35: Not acidemia. Consider metabolic alkalosis or normal acid-base with mixed picture.
Step 2: Assess Respiratory Compensation Using Winter’s Formula
Expected PCO2 = 1.5 × [HCO3] + 8 ± 2
Compare actual PCO2 to expected:
- Actual PCO2 within ±2 of expected: Appropriate respiratory compensation (isolated metabolic acidosis or mixed without primary respiratory disorder)
- Actual PCO2 HIGHER than expected: Primary respiratory acidosis ALSO present (concurrent hypoventilation)
- Actual PCO2 LOWER than expected: Primary respiratory alkalosis ALSO present (excessive hyperventilation)
Action: If PCO2 does not match expectation, immediately consider: - Pulmonary pathology (edema, pneumonia, PE) - CNS pathology (altered mental status limiting drive to breathe, or excessive drive from acidosis, pain, anxiety) - Acid-base disorder combined with respiratory disorder
Step 3: Calculate Anion Gap (With Albumin Correction)
AG = [Na] − ([Cl] + [HCO3])
First, identify if patient is hypoalbuminemic: - If albumin < 4 g/dL, correct the AG: Adjusted AG = Measured AG + 2.5 × (4 − [Albumin])
Interpretation: - Adjusted AG > 12: HIGH ANION GAP → proceed to Step 4 - Adjusted AG ≤ 12: NORMAL ANION GAP → proceed to Step 5
Step 4: If High Anion Gap → Determine Cause and Calculate Delta-Delta
HAGMA causes (GOLDMARK): - Glycols (ethylene glycol, propylene glycol) - Oxoproline (5-oxoproline/pyroglutamic acidosis) - L-lactate - DKA / alcoholic ketoacidosis / starvation ketoacidosis - Methanol - Aspirin (salicylate) - Renal failure (uremia) - Ketoacidosis
Diagnostic workup for HAGMA: - Lactate level: Is elevated lactate present? (lactic acidosis vs. other cause) - Glucose + beta-hydroxybutyrate/urine ketones: Is DKA present? - Osmolar gap + serum methanol/ethylene glycol: Is toxin ingestion present? - Acetaminophen history + urine pyroglutamic acid: Is pyroglutamic acidosis present? - Salicylate level: Is aspirin toxicity present? - Renal function (creatinine): Is uremia the cause?
Then calculate delta-delta: ΔAG = AG − 12 ΔHCO3 = 24 − [HCO3] Ratio = ΔAG/ΔHCO3
- Ratio < 1: HAGMA + NAGMA (combined)
- Ratio 1–2: Pure HAGMA
- Ratio > 2: HAGMA + metabolic alkalosis (hidden)
Action: Based on cause identified and ratio, pursue targeted treatment.
Step 5: If Normal Anion Gap → Calculate Urine Anion Gap
UAG = [UNa + UK] − [UCl]
OR assess urine osmolar gap / direct urine ammonium (if available)
Interpretation: - UAG < –20 (negative): Appropriate high urine NH4+ excretion → kidneys working normally → GI CAUSE (diarrhea, fistula, etc.) - Action: Replace HCO3; treat underlying GI disorder
- UAG > 0 (positive): Low urine NH4+ excretion → kidneys cannot respond to acidosis → RENAL CAUSE (RTA, Addison’s, acetazolamide, hyperkalemia)
- Action: Identify type of RTA; check serum K+; obtain aldosterone/renin
Additional diagnostic clues for NAGMA cause (USEDCARP): - History of diarrhea → diarrhea (most common) - Known ureteral diversion → ureterosigmoidostomy - Recent diuretic use + low urine Cl → Addison’s disease or hypoaldosteronism - Medication history → carbonic anhydrase inhibitor (acetazolamide) or thiazide - Serum K+ is ELEVATED → Type IV RTA or Addison’s disease - Urine pH > 5.5 despite acidemia → Type I RTA - Serum HCO3 improves with saline loading → Type II RTA (proximal)
Step 6: Special Situations — Consider Stewart Approach
In complex ICU patients or when traditional approach is non-diagnostic: - Calculate corrected AG (done in Step 3 already) - Quantify hyperchloremic effect: Cl - 98 - Quantify hypoalbuminemic effect: 0.25 × (42 - albumin in g/L) - This may reveal diagnosis where traditional approach failed
Flowchart Summary
METABOLIC ACIDOSIS SUSPECTED
↓
[Step 1] Confirm: pH < 7.35, HCO3 < 22, PCO2 < 40
↓
[Step 2] Check Winter's Formula for appropriate PCO2
PCO2 matches ±2? → Isolated MA or MA + resp alk (if lower)
PCO2 higher than expected? → Concurrent respiratory acidosis
↓
[Step 3] Calculate AG (with albumin correction if Alb < 4)
├─ AG > 12 → HIGH ANION GAP
│ ↓
│ [Step 4] HAGMA workup:
│ - Lactate? Glucose/ketones? Osmolar gap?
│ - Identify cause (GOLDMARK)
│ - Calculate delta-delta ratio
│ - Treat specific cause
│
└─ AG ≤ 12 → NORMAL ANION GAP
↓
[Step 5] NAGMA workup:
- Calculate UAG or urine osmolar gap
- UAG < –20 (negative) → GI cause (diarrhea)
- UAG > 0 (positive) → Renal cause (RTA, Addison's)
- Identify specific cause (USEDCARP)
- Treat specific cause
12. References and Literature
- Lactic Acidosis:
- Kraut JA, Madias NE. Lactic Acidosis. N Engl J Med. 2014;371:2309-19. PMID: 25494270
- Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010;6:274-85. PMID: 20308999
- Pyroglutamic Acidosis (5-Oxoproline):
- Duewall JL, et al. Increased Anion Gap Metabolic Acidosis from 5-Oxoproline. J Crit Illness. 2006. PMID: 15983968
- Fenves AZ, et al. 5-Oxoproline Acidosis Associated with Chronic Acetaminophen Use. Clin Nephrol. 2007. PMID: 17699243
- Urine Anion Gap and Ammonium:
- Batlle DC, et al. Use of the Urinary Anion Gap in the Diagnosis of Hyperchloremic Metabolic Acidosis. N Engl J Med. 1988;318:594-9. PMID: 3344005
- Batlle D, et al. The Urine Anion Gap in Context. Clin J Am Soc Nephrol. 2018;13:195-7. PMID: 29311217
- Rehman MZ, et al. Urinary Ammonium in Clinical Acid-Base Assessment. PMID: 36868734
- Anion Gap Concepts:
- Goodkin DA, Krishna GG, Narins RG. Role of Anion Gap in Detecting and Managing Mixed Metabolic Acid-Base Disorders. Clin Nephrol. 1984;22:160-6. PMID: 6488577
- Wrenn K. The Delta (Delta) Gap: An Approach to Mixed Acid-Base Disorders. Ann Emerg Med. 1990;19:1310-3. PMID: 2240729
- Stewart (Physicochemical) Approach:
- Story DA, et al. A Simplified Approach to Treatment of Acute Metabolic Acidosis. Br J Anaesth. 2004;92:54-60. PMID: 14665553
- Fencl V, et al. Diagnosis of Metabolic Acid-Base Disturbances in Critically Ill Patients. Am J Respir Crit Care Med. 2000;162:2246-51.
- CKD and Metabolic Acidosis:
- Kraut JA, Madias NE. Metabolic Acidosis of Chronic Kidney Disease: Core Curriculum 2021. Am J Kidney Dis. 2021;77:275-88. PMID: 26477665
- KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013.
- Toxicology:
- References for methanol, ethylene glycol, salicylate toxicity available in specialized toxicology databases and Poisindex
Key Clinical Pearls Summary
This document is a living resource for nephrology education. Update with new evidence, clinical pearls, or additional references as vault content evolves. Last reviewed: 2026-02-28
[[Electrolyte-Hub|← Back to Electrolyte-Acid-Base Hub]]